SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biogen Says Diranersen Was Well Tolerated Through Two Years

Biogen reported no new safety signals for diranersen through two years.

BIIB

Related stories